首页>American Journal of Dermatopathology>Changes in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor
Changes in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor
作者单位：Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX[1]Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States[2]Department of Pathology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston[3]Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, TX, United States[4]
换一批
换一批
